Manmohan Mahajan Takes the Helm as New CFO at Prime Therapeutics
Manmohan Mahajan Takes the Helm as New CFO at Prime Therapeutics
Prime Therapeutics LLC has officially announced the appointment of Manmohan Mahajan as its new chief financial officer (CFO), effective immediately. This strategic move comes as the company aims to enhance its leadership team amidst an evolving healthcare landscape.
Mahajan is no stranger to the finance world, boasting over 20 years of extensive experience in finance and leadership. He has spent a significant portion of his career in healthcare, pharmacy, and financial services, which equips him with the knowledge and expertise required to navigate the complexities of pharmacy care today. Additionally, Mahajan will be part of the leadership team led by Mostafa Kamal, Prime's president and CEO.
In his statement, Kamal expressed confidence in Mahajan's capabilities, noting, "Manmohan brings deep healthcare and pharmacy experience, along with a proven ability to lead large, complex organizations through transformation and growth." This sentiment underscores the belief that Mahajan's leadership will be crucial in helping the company fulfill its mission of improving affordability, simplifying the member experience, and achieving optimal health outcomes for its clients.
Prior to joining Prime, Mahajan served as the executive vice president and global CFO of Walgreens Boots Alliance, where he dedicated a decade to finance leadership, taking on various roles that showcased his ability in leading large-scale transformations, ensuring cost discipline, and simplifying organizational structures. His career journey also includes senior finance positions at GE Capital, extending over 13 years, which further solidifies his standing in the financial sector.
Reflecting on his new role at Prime, Mahajan stated, "I am excited to join Prime, and to be a part of a company and culture that is committed to making healthcare more affordable and accessible." He looks forward to collaborating with Kamal and the rest of the leadership team to steer Prime as a leader in pharmacy solutions, delivering long-term value for both payers and patients.
This appointment marks a significant change in the company's leadership, as Mahajan succeeds Ken Bodmer, who previously held the CFO position. Bodmer will transition into a part-time advisory role, continuing to lend his expertise to Prime during this crucial phase. Kamal acknowledged Bodmer’s contributions, thanking him for his steady leadership and partnership during a pivotal period for Prime.
About Prime Therapeutics
Prime Therapeutics LLC is a pharmacy solutions partner that champions savings, simplicity, and support for its customers and members. The organization prides itself on providing care to millions across the nation through innovative pharmacy benefit management, specialty and medical drug management, as well as state government solutions. Prime stands out in the pharmacy industry by adhering to a conflict-free approach, implementing cutting-edge technology, and emphasizing a purpose that transcends profits. For more information, visit the Prime Therapeutics website or find them on LinkedIn.
In summary, the appointment of Manmohan Mahajan as CFO at Prime Therapeutics is expected to drive transformational changes in the company's approach to healthcare, marking a pivotal moment in its evolution as a pharmacy solutions leader.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.